Low-Level Quantitation of Formaldehyde in Drug Substance by HPLC–UV

被引:0
|
作者
A. Nageswari
K. V. S. R. Krishna Reddy
K. Mukkanti
机构
[1] Jawaharlal Nehru Technological University,Center of Pharmaceutical Sciences, IST
[2] Aptuit Laurus Private Limited,undefined
[3] ICICI Knowledge Park,undefined
来源
Chromatographia | 2012年 / 75卷
关键词
HPLC–UV; Derivatization; Genotoxic impurity; Chromophore; Active pharmaceutical ingredient;
D O I
暂无
中图分类号
学科分类号
摘要
Formaldehyde has been highlighted as potential genotoxic impurity (GTI). Trace-level quantification of GTIs in drug substances requires sensitive, precise and accurate analytical methodologies for their estimation in drug substances and control. Analysis and estimation of formaldehyde is very challenging due to its properties namely volatility, high polarity, low molecular weight and over and above the absence of chromophore. This article presents a validated HPLC–UV method which is sensitive to quantification of formaldehyde in active pharmaceutical ingredient. As formaldehyde does not possess chromophore, the developed HPLC method involves derivatization with 2,4-dinitrophenylhydrazine. Using this method, the detection and quantitation limits achieved are 0.5 and 1.5 ppm, respectively. The calibration curve of formaldehyde was linear over the concentration range of 1.5–20 ppm. The method was found to be sensitive, precise and accurate and the proposed method has been successfully applied to estimate formaldehyde content in scale-up batches of bulk drug.
引用
收藏
页码:275 / 280
页数:5
相关论文
共 50 条
  • [1] Low-Level Quantitation of Formaldehyde in Drug Substance by HPLC-UV
    Nageswari, A.
    Reddy, K. V. S. R. Krishna
    Mukkanti, K.
    [J]. CHROMATOGRAPHIA, 2012, 75 (5-6) : 275 - 280
  • [2] HPLC-UV method development and validation for the determination of low level formaldehyde in a drug substance
    Soman, A.
    Qiu, Y.
    Li, Q. Chan
    [J]. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2008, 46 (06) : 461 - 465
  • [3] Low-level haemolysis negatively interferes with quantitation of vitamin E by the Chromsystems HPLC assay
    Hughes, Chris
    Collingwood, Catherine
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2022, 59 (05) : 378 - 380
  • [4] LOW-LEVEL FORMALDEHYDE IN BRONCHIAL-ASTHMA
    HARVING, H
    PEDERSEN, OF
    KORSGAARD, J
    MOLHAVE, L
    DAHL, R
    [J]. BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S95 - S95
  • [5] LOW-LEVEL DRUG ENFORCEMENT
    DORN, N
    MURJI, K
    [J]. INTERNATIONAL JOURNAL OF THE SOCIOLOGY OF LAW, 1992, 20 (02): : 159 - 171
  • [7] HEALTH-EFFECTS OF LOW-LEVEL EXPOSURE TO FORMALDEHYDE
    MAIN, DM
    HOGAN, TJ
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1983, 25 (12) : 896 - 900
  • [8] EFFECTS OF LOW-LEVEL FORMALDEHYDE EXPOSURE ON PULMONARY STATUS
    MAIN, D
    HOGAN, T
    [J]. SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 1983, 9 (01) : 60 - 60
  • [9] ACUTE LOW-LEVEL FORMALDEHYDE BEHAVIORAL AND NEUROCHEMICAL TOXICITY IN THE RAT
    BOJA, JW
    NIELSEN, JA
    FOLDVARY, E
    TRUITT, EB
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1985, 9 (5-6): : 671 - 674
  • [10] QUANTITATION OF LOW-LEVEL IMMUNOGLOBULIN-E, UTILIZING COMMERCIAL REAGENTS
    MCGEE, N
    MANDY, FF
    PERELMUTTER, L
    [J]. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (08): : 768 - 768